SET welcomes listing of herbal product manufacturer and distributor "SNPS"

SNPS and its subsidiaries are manufacturers and distributors of standardized botanical extracts and active phyto-ingredients, serving multiple industries from cosmetics and cosmeceuticals to function foods, dietary supplements, and pharmaceuticals. The company provides comprehensive services in plant extraction, research and development, and analytical testing. SNPS has also strategically expanded into health, beauty, and wellness segments through two key business channels: Original Design Manufacturing (ODM), which offers end-to-end solutions including product consultation, formulation development, packaging design, and Thai Food and Drug Administration (FDA) registration assistance, and Original Brand Manufacturing (OBM), through which it has successfully commercialized several proprietary products backed by proven research and innovations. Its house brand portfolio includes Nine Herbs Green Balm For Relieve Itching, Madame Thai Herb andrographis paniculata extract products, Phytae plant-based protein powder, and Colosure supplementary diet products.

Following the initial public offering (IPO), SNPS has a paid-up capital of THB 405 million with a par value of THB 1 per share. The company offered 105 million IPO shares from November 21-22 and 25, 2024 to subscribers at the underwriters' discretion, the patrons, directors, executives and employees of the company and its subsidiaries, and related parties of the company. The IPO price was set at THB 4.2 per share, representing THB 441 million in fund raised and a market capitalization of THB 1.70 billion (approximately USD 49 million) at its IPO. Finansia Syrus Securities pcl is the financial advisor and lead underwriter.

SNPS Chief Executive Office Theeraya Krisdaphong highlighted that SNPS is an innovator in Thai herbal extraction, strategically focusing on sustainable active-phyto innovations and comprehensive research and development initiatives to create distinctive, high-quality products. She emphasized the company's ambitious plans to actively broaden its proprietary portfolio of active-phyto ingredients and products, positioning SNPS to tap into growing demand for natural ingredients and raw materials across both established and new markets. The company's IPO proceeds will be invested advanced herbal extraction and purification technology as well as research, development and production of raw materials for herbal products and medical or specialty food products.

Following the IPO, SNPS' principal shareholder is the Krisdaphong family (74.07 percent). The company's dividend policy is to distribute a minimum of 30 percent of its net profit based on the separate financial statements after corporate income tax, all legally mandated reserves, and provisions under the company's bylaws. Dividend decisions will also be based on consideration of relevant factors to serve the best interests of the shareholders.

For more information on SNPS, please see the company's prospectus at the Securities and Exchange Commission's website at www.sec.or.th; and for general information, please visit www.snpspcl.com and www.set.or.th.